Feng Zhang named 2016 Tang Prize laureate
Broad Institute/MIT scientist among three honored for CRISPR contributions.
New CRISPR system for targeting RNA
Scientists program C2c2, discovered in bacteria as a viral defense mechanism, to manipulate cellular RNA.
Feng Zhang receives 2016 Canada Gairdner International Award
Broad/MIT scientist among five honored as pioneers of CRISPR-Cas9 system.
Toward a better understanding of the brain
Genome-editing pioneer Feng Zhang hopes his work will shed light on neurological disorders.
Faster drug discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
MIT, Broad scientists overcome key CRISPR-Cas9 genome editing hurdle
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
New system for human genome editing has potential to increase power and precision of DNA engineering
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
An easier way to manipulate malaria genes
New approach to knocking out parasite’s genes could make it easier to identify drug targets.
3 Questions: Kenneth Oye on the regulation of genetic engineering
Political scientist discusses regulatory gaps in assessing the impact of “gene drives.”
MRI reveals genetic activity
New MIT technique could help decipher genes’ roles in learning and memory.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.